Clinician Prescribing Practices Involving Medications for Alcohol Use Disorder.

ABSTRACT:

Introduction

Despite the heavy toll of alcohol use disorder (AUD) in the U.S., efficacious medications for AUD (MAUD) are rarely used. Minimal research has explored clinician prescribing practices involving MAUD.

Methods

Using a large national database of electronic health records, this cross-sectional analysis, conducted in 2023-2024, identified clinicians with at least 1 prescription order for an FDA-approved MAUD (naltrexone, acamprosate, or disulfiram) for a patient with AUD during 2016-2021. Descriptive statistics captured clinician-level prescribing volume and type of medication prescribed. Logistic regression models estimated the association between clinician characteristics and number of MAUD patients and type of medications prescribed.

Results

Among the 38,62

SUBMITTER: Kennedy-Hendricks A 

PROVIDER: S-EPMC11830549 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature